✦ LIBER ✦

Targeting death-inducing receptors in cancer therapy

✍ Scribed by Takeda, K; Stagg, J; Yagita, H; Okumura, K; Smyth, M J

Book ID: 110072372
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 346 KB
Volume: 26
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1210374

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Death receptors in cancer therapy

✍ Suzuki, Y; Rufini, A; Belfield, H 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Death receptor-induced cell death in pro

Death receptor-induced cell death in prostate cancer

✍ Natalya V. Guseva; Agshin F. Taghiyev; Oskar W. Rokhlin; Michael B. Cohen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

## Abstract Prostate cancer mortality results from metastasis and is often coupled with progression from androgen‐dependent to androgen‐independent growth. Unfortunately, no effective treatment for metastatic prostate cancer increasing patient survival is available. The absence of effective therapi

Kinin receptors as targets for cancer th

Kinin receptors as targets for cancer therapy

✍ Figueroa, Carlos D; Ehrenfeld, Pamela; Bhoola, Kanti D 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 487 KB

Targeting survivin in cancer therapy

✍ Pennati, Marzia; Folini, Marco; Zaffaroni, Nadia 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 504 KB

Targeting Histone Deacetylase in Cancer

Targeting Histone Deacetylase in Cancer Therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A